Gujarat Themis secures $58 million private credit for Japanese acquisition ...Middle East

Founded in 1981, Gujarat Themis is India's first company to start commercial production of the anti-tuberculosis drug Rifampicin, according to its website

Hence then, the article about gujarat themis secures 58 million private credit for japanese acquisition was published today ( Tuesday 29/09/2026 - 06:45 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gujarat Themis secures $58 million private credit for Japanese acquisition )

Also on site :

• JAAM AUTOMATION LAUNCHES NEW AI PLATFORM TO BRING PEOPLE, SYSTEMS AND AI TOGETHER TO MANAGE COMPLEX BUSINESS PROCESSES
• BRC Group Holdings, Inc. Agrees to Acquire Sangoma Technologies Corporation to Scale Communications Portfolio
• askelie® launches askVERA, a new Easy Read AI platform to make complex documents easier to understand